{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:12:21Z","timestamp":1792699941462,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.semarthrit.2024.152521","type":"journal-article","created":{"date-parts":[[2024,7,18]],"date-time":"2024-07-18T20:05:11Z","timestamp":1721333111000},"page":"152521","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1256-0761","authenticated-orcid":false,"given":"Stefano","family":"Di Donato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D","family":"Pauling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Del Galdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Sabbagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152521_bib0001","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1007\/s10067-019-04745-5","article-title":"Raynaud's phenomenon\u2014an update on diagnosis, classification and management","volume":"38","author":"Pauling","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0002","doi-asserted-by":"crossref","unstructured":"Hughes, M. & Shah. A.A. Other Secondary Causes. In: Wigley, F. M., Herrick, A. L. & Flavahan, N. A. (eds). Raynaud's phenomenon a guide to pathogenesis and treatment. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-031-52581-0_9 (2024).","DOI":"10.1007\/978-3-031-52581-0_9"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0003","doi-asserted-by":"crossref","first-page":"658","DOI":"10.12968\/hmed.2019.80.11.658","article-title":"Raynaud's phenomenon","volume":"80","author":"Devgire","year":"2019","journal-title":"Br J Hosp Med (Lond)"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0004","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJMra1507638","article-title":"Raynaud's Phenomenon","volume":"375","author":"Wigley","year":"2016","journal-title":"NEJM"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0005","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/acr.24710","article-title":"Factors influencing patient decision-making concerning treatment escalation in Raynaud's phenomenon secondary to systemic sclerosis","volume":"73","author":"Hughes","year":"2021","journal-title":"Arthrit Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0006","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/acr.23475","article-title":"A multi-national qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis","volume":"70","author":"Pauling","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0007","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/rheumatology\/kev002","article-title":"Prediction and impact of attacks of Raynaud's phenomenon, as judged by patient perception","volume":"54","author":"Hughes","year":"2015","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0008","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archinte.158.6.595","article-title":"Outcomes in Primary Raynaud Phenomenon: a Meta-analysis of the Frequency, Rates, and Predictors of Transition to Secondary Diseases","volume":"158","author":"Spencer-Green","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0009","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7861\/clinmed.2020-0754","article-title":"Raynaud's phenomenon","volume":"20","author":"Haque","year":"2020","journal-title":"Clin Med"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0011","doi-asserted-by":"crossref","first-page":"6389","DOI":"10.1136\/bmjopen-2014-006389","article-title":"Prevalence, risk factors and associations of primary Raynaud's phenomenon: systematic review and meta-analysis of observational studies","volume":"5","author":"Garner","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0012","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/rheumatology\/keaa680","article-title":"Epidemiology of systemic sclerosis in the UK: an analysis of the Clinical Practice Research Datalink","volume":"60","author":"Pauling","year":"2021","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0013","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0014","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative Arthritis & Rheumatism","volume":"65","author":"Van Den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0015","doi-asserted-by":"crossref","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","article-title":"Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS)","volume":"3","author":"Bellando-Randone","year":"2021","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0016","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.semarthrit.2021.04.005","article-title":"Developing a core set of outcome measure domains to study Raynaud's phenomenon and digital ulcers in systemic sclerosis: report from OMERACT 2020","volume":"51","author":"Maltez","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152208","article-title":"Domain reporting in systemic sclerosis-related Raynaud's phenomenon: an OMERACT scoping review","volume":"61","author":"Maltez","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0018","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/1744666X.2018.1464390","article-title":"The challenge of establishing treatment efficacy for cutaneous vascular manifestations of systemic sclerosis","volume":"14","author":"Pauling","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0019","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s10067-021-05598-7","article-title":"How do patients define Raynaud's phenomenon? Differences between primary and secondary disease","volume":"40","author":"Murphy","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0020","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1007\/s10067-022-06206-y","article-title":"The clinical relevance of Raynaud's phenomenon symptom characteristics in systemic sclerosis","volume":"41","author":"Hughes","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0021","first-page":"e21681","article-title":"Raynaud's phenomenon: reviewing the pathophysiology and management strategies","volume":"14","author":"Nawaz","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0022","doi-asserted-by":"crossref","first-page":"e611","DOI":"10.1016\/S2665-9913(23)00189-3","article-title":"MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study","volume":"5","author":"Hughes","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0023","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0024","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/1756-185X.14042","article-title":"Large fiber peripheral neuropathy in systemic sclerosis: a prospective study using clinical and electrophysiological definition","volume":"24","author":"Raja","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152268","article-title":"Autonomic dysfunction in systemic sclerosis: a scoping review","volume":"63","author":"Di Battista","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0026","article-title":"Digital ulc clerosis","volume":"48","author":"Steen","year":"2009","journal-title":"Rheumatol (Oxf)"},{"key":"10.1016\/j.semarthrit.2024.152521_bib0027","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/rheumatology\/keab850","article-title":"Improvement with time of vascular outcomes in systemic sclerosis: a systematic review and meta-analysis study","volume":"61","author":"Hughes","year":"2022","journal-title":"Rheumatol (Oxf)"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:14:32Z","timestamp":1726618472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":26,"alternative-id":["S0049017224001616"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152521","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152521","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152521"}}